I. Schiattino

发表

Multiple imputation procedures allow the rescue of missing data: an application to determine serum tumor necrosis factor (TNF) concentration values during the treatment of rheumatoid arthritis patients with anti-TNF therapy.

R. Villegas, J. Cuenca, J. Aguillón, 2005, Biological research.

Genetic polymorphism at position-308 in the promoter region of the tumor necrosis factor (TNF): implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population.

J. Cuenca, A. Aguirre, J. Aguillón, 2001, Biological research.

Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis.

J. Cuenca, A. Aguirre, J. Aguillón, 2004, Scandinavian journal of rheumatology.

Tumour necrosis factor‐α (TNF‐α) levels and influence of −308 TNF‐α promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis

A. Aguirre, F. Salazar-Onfray, M. Aliste, 2004 .

[Characteristics of employment and wellbeing among physicians working in Santiago, Chile].

I. Schiattino, J. Jimenez, J. Acuña, 2013, Revista medica de Chile.

Quality of life in climacteric Chilean women treated with low-dose estrogen.

S. Aedo, G. Cavada, I. Schiattino, 2008, Maturitas.

Ex vivo lipopolysaccharide (LPS)‐induced TNF‐α, IL‐1β, IL‐6 and PGE 2 secretion in whole blood from Type 1 diabetes mellitus patients with or without aggressive periodontitis

A. Aguirre, J. Aguillón, I. Schiattino, 2003 .

Ex vivo lipopolysaccharide (LPS)-induced TNF-alpha, IL-1beta, IL-6 and PGE2 secretion in whole blood from Type 1 diabetes mellitus patients with or without aggressive periodontitis.

A. Aguirre, J. Aguillón, I. Schiattino, 2003, European cytokine network.

The -308 polymorphism in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene and ex vivo lipopolysaccharide-induced TNF-alpha expression in patients with aggressive periodontitis and/or type 1 diabetes mellitus.

J. Cuenca, A. Aguirre, Arturo Ferreira, 2004, European cytokine network.

[A survey about physicians’ professional satisfaction].

I. Schiattino, J. Jimenez, J. Acuña, 2011, Revista medica de Chile.

Tumour necrosis factor (TNF)α −308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis

J. Aguillón, C. Llanos, F. Salazar-Onfray, 2006 .

[Generation and validation of a scale to measure physicians' wellbeing].

I. Schiattino, J. Jimenez, J. Acuña, 2010, Revista medica de Chile.

[Effects of estrogen supplementation on psychological variables in climacteric women].

J. Blümel, F. Lolas, I. Schiattino, 1996, Revista medica de Chile.

The -308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis.

J. Cuenca, A. Aguirre, J. Aguillón, 2003, Rheumatology.

The 2 308 polymorphism in the tumour necrosis factor ( TNF ) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis

J. Cuenca, A. Aguirre, J. Aguillón, 2003 .

Tumour necrosis factor (TNF)alpha -308 G/G promoter polymorphism and TNFalpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritis.

J. Aguillón, C. Llanos, F. Salazar-Onfray, 2006, Scandinavian journal of rheumatology.

Impact of large industrial emission sources on mortality and morbidity in Chile: A small-areas study.

Irene Schiattino, S. Mesías, P. Ruiz-Rudolph, 2016, Environment international.

TEACHING REGRESSION MODELS: AN APPLICATION WITH SIMULATIONS

Claudio Silva, Rosa Montaño, Irene Schiattino, 2010 .